Although early study has reported SEMA5B upregulation in clear cell renal carcinoma (ccRCC) and suggested the role of SEMA5B in tumor growth (Kundu et al., 2020), there is a lack of comprehensive studies on the clinical role of SEMA5B. Here, SEMA5B is linked to nonpapillary renal cell carcinoma.